Get Real Time Here
| Open1.710 | Close1.770 |
| Vol / Avg.630.602K / 349.781K | Mkt Cap84.846M |
| Day Range1.710 - 1.910 | 52 Wk Range1.240 - 11.710 |
BioAtla Stock (NASDAQ:BCAB), Quotes and News Summary
BioAtla Stock (NASDAQ: BCAB) stock price, news, charts, stock research, profile.
| Open1.710 | Close1.770 |
| Vol / Avg.630.602K / 349.781K | Mkt Cap84.846M |
| Day Range1.710 - 1.910 | 52 Wk Range1.240 - 11.710 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.800 | -0.700 | 0.1000 | ||||
| REV | 0 |
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.620 | -0.750 | -0.1300 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-11-08 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 17.00 | 10.00 |
| 2023-09-25 | JP Morgan | Brian Cheng | Maintains | OverweightOverweight | Lowers | 17.00 | 14.00 |
| 2023-08-02 | JP Morgan | Brian Cheng | Maintains | OverweightOverweight | Lowers | 19.00 | 17.00 |
| 2023-08-02 | JMP Securities | Reni Benjamin | Reiterates | Market OutperformMarket Outperform | Maintains | - | 12.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCAB | BioAtla | 4.12% | 84.8M |
| NKGN | NKGen Biotech | -0.59% | 73.3M |
| CTMX | CytomX Therapeutics | 3.01% | 91.8M |
| ADVM | Adverum Biotechnologies | -1.38% | 81.7M |
| CRIS | Curis | 19.73% | 87M |
How do I buy BioAtla (BCAB) stock?
You can purchase shares of BioAtla (NASDAQ: BCAB) through any online brokerage.
Who are BioAtla's (BCAB) competitors?
Other companies in BioAtla’s space includes: NKGen Biotech (NASDAQ:NKGN), CytomX Therapeutics (NASDAQ:CTMX), Adverum Biotechnologies (NASDAQ:ADVM), Curis (NASDAQ:CRIS) and Burning Rock Biotech (NASDAQ:BNR).
What is the target price for BioAtla (BCAB) stock?
The latest price target for BioAtla (NASDAQ: BCAB) was reported by HC Wainwright & Co. on Wednesday, November 8, 2023. The analyst firm set a price target for 10.00 expecting BCAB to rise to within 12 months (a possible 464.97% upside). 17 analyst firms have reported ratings in the last year.
Current Stock Price for BioAtla (BCAB)?
The stock price for BioAtla (NASDAQ: BCAB) is $1.77 last updated Today at November 30, 2023 at 9:20 PM UTC.
Does BioAtla (BCAB) pay a dividend?
There is no dividend information for BioAtla.
When is BioAtla (NASDAQ:BCAB) reporting earnings?
BioAtla’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is BioAtla (BCAB) going to split?
There is no upcoming split for BioAtla.
What sector and industry does BioAtla (BCAB) operate in?
BioAtla is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.